Haleh Hamedifar | Chief Executive Officer And Pharmacist
Singapore Biotech

Prior to Singapore Biotech, Dr. Hamedifar was the CEO of CinnaGen for 14 years. She was the founder of CinnaGen Group as well as CinnaGen’s seven sister companies. Under her leadership, she transformed the company from a diagnostic manufacturer to a global biopharmaceutical company, increasing sales exponentially by entering highly regulated markets and through technology licensing and technology transfer deals with international partners.
Dr. Hamedifar led the company to develop an unprecedented portfolio of biosimilar medicines and drove innovation in industrial pharmaceutical manufacturing procedures, resulting in world class biotech manufacturing technology and facilities. Her vision and strategy has made CinnaGen a well known and respected pharmaceutical company standing at the center of science and innovation in terms of manufacturing biosimilar products in the MENA region.